Transplantation and cellular therapy

Cyclophosphamide and thiotepa increases risk of transplant-associated thrombotic microangiopathy.

Transplantation and cellular therapy

Higham CS, Shimano KA, Kharbanda S, Chu J, Cisneros GS, Winestone LE, Dara J, Huang JN, Hermiston ML, Long-Boyle JR, Dvorak CC

A Cure for Sickle Cell Disease.

Transplantation and cellular therapy

Walters M

Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients.

Transplantation and cellular therapy

Cheng G, Smith MA, Phelan R, Brazauskas R, Strom J, Ahn KW, Hamilton B, Peterson A, Savani B, Schoemans H, Schoettler M, Sorror M, Higham C, Kharbanda S, Dvorak CC, Zinter MS

The Relationship Between Busulfan Exposure and Achievement of Sustained Donor Myeloid Chimerism in Patients with Non-Malignant Disorders.

Transplantation and cellular therapy

Apsel Winger B, Shukla P, Kharbanda S, Keizer RJ, Goswami S, Cowan MJ, Dvorak CC, Long-Boyle J

A Phase 1 Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Children, Adolescents and Young Adults with High-Risk T-Cell Acut

Transplantation and cellular therapy

Allyson Flower, Troy C. Quigg, David T. Teachey, Megan Lim, Yanling Liao, Lauren Harrison, Erin Morris, Amir Steinberg, Stephan Voss, Rodney R Miles, Xiaokui Mo, Joseph Stanek, Adam Olshen, Michelle Hermiston, Alix E. Seif, Mitchell S. Cairo

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.

Transplantation and cellular therapy

Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM

Fludarabine Pharmacokinetic-Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Mismatched Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy

Christopher C. Dvorak, William C. Temple, Gabriel Salinas Cisneros, Julia Chu, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, Sandhya Kharbanda, Serine Avagyan, Michelle Hermiston, James N. Huang, Janel Renee Long-Boyle

Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in Children.

Transplantation and cellular therapy

Forlanini F, Zinter MS, Dvorak CC, Bailey-Olson M, Winestone LE, Shimano KA, Higham CS, Melton A, Chu J, Kharbanda S

High Exposure of Intravenous Alemtuzumab Is Associated with Increased Risk of Double-Stranded DNA Viral Infections in Patients with Non-Malignant Disease Undergoing Allogeneic HCT.

Transplantation and cellular therapy

Gabriel Salinas Cisneros, Janel Renee Long-Boyle, William C. Temple, Julia Chu, Serine Avagyan, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, James N. Huang, Michelle Hermiston, Sandhya Kharbanda, Christopher C. Dvorak

Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy

Bogn?r T, Bartelink IH, Egberts TCG, Rademaker CMA, Versluys AB, Slatter MA, Kletzel M, Nath CE, Cuvelier GDE, Savic RM, Dvorak C, Long-Boyle JR, Cowan MJ, Bittencourt H, Bredius RGM, G?ng?r T, Shaw PJ, Ansari M, Hassan M, Krajinovic M, Hempel G, Marktel S, Chiesa R, Th?oret Y, Lund T, Orchard PJ, Wynn RF, Boelens JJ, Lalmohamed A

Pages